Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The ...
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving ...
HOUSTON and SALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and ... Genetics and the clinical and translational research expertise of MD ...
Being evaluated for the treatment of metastatic colorectal cancer, the combination regimen achieved an objective response ...
News Medical on MSN6d
Dual-targeted therapy plus chemo boosts response rate in BRAF-mutated metastatic colorectal cancerPatients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...
The Mayo Clinic provides a perspective on 7 ways that individuals can reduce their risk: Eat healthier foods (thereby also ...
Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ ...
A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast Recurrence Score® result ...
Verywell Health on MSN3d
10 Strategies to Help With Appetite Loss Associated With Metastatic Breast CancerMetastatic breast cancer and breast cancer treatment can cause symptoms that produce appetite loss, but there are strategies to help. Here are the top tips.
The Mike Slive Foundation has named the recipients of six prostate cancer research grants. The grants are aimed at continuing the foundation’s stated mission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback